784 related articles for article (PubMed ID: 25944654)
1. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
Black AP; Cardozo LF; Mafra D
Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654
[TBL] [Abstract][Full Text] [Related]
2. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.
Filipska I; Winiarska A; Knysak M; Stompór T
Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
[TBL] [Abstract][Full Text] [Related]
4. Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction.
Fujii H; Goto S; Fukagawa M
Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772660
[TBL] [Abstract][Full Text] [Related]
5. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
Liu WC; Tomino Y; Lu KC
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
[TBL] [Abstract][Full Text] [Related]
6. Uremic Vascular Calcification: The Pathogenic Roles and Gastrointestinal Decontamination of Uremic Toxins.
Chao CT; Lin SH
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33371477
[TBL] [Abstract][Full Text] [Related]
7. Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial.
Ramos CI; Armani RG; Canziani MEF; Dalboni MA; Dolenga CJR; Nakao LS; Campbell KL; Cuppari L
Nephrol Dial Transplant; 2019 Nov; 34(11):1876-1884. PubMed ID: 29939302
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
[TBL] [Abstract][Full Text] [Related]
9. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.
Castillo-Rodriguez E; Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Fernandez-Fernandez B; Kanbay M; Tejedor A; Lazaro A; Ruiz-Ortega M; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30029499
[TBL] [Abstract][Full Text] [Related]
10. The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
[TBL] [Abstract][Full Text] [Related]
11. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N
Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327
[TBL] [Abstract][Full Text] [Related]
12. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
[TBL] [Abstract][Full Text] [Related]
13. Circulating
Chang JF; Hsieh CY; Liou JC; Lu KC; Zheng CM; Wu MS; Chang SW; Wang TM; Wu CC
Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357951
[TBL] [Abstract][Full Text] [Related]
14. P
Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
[TBL] [Abstract][Full Text] [Related]
15. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
[TBL] [Abstract][Full Text] [Related]
16. Protein-Bound Uremic Toxins and Immunity.
Rocchetti MT; Cosola C; Ranieri E; Gesualdo L
Methods Mol Biol; 2021; 2325():215-227. PubMed ID: 34053061
[TBL] [Abstract][Full Text] [Related]
17. Disposition and clinical implications of protein-bound uremic toxins.
Jansen J; Jankowski J; Gajjala PR; Wetzels JFM; Masereeuw R
Clin Sci (Lond); 2017 Jul; 131(14):1631-1647. PubMed ID: 28667064
[TBL] [Abstract][Full Text] [Related]
18. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
Lau WL; Savoj J; Nakata MB; Vaziri ND
Clin Sci (Lond); 2018 Mar; 132(5):509-522. PubMed ID: 29523750
[TBL] [Abstract][Full Text] [Related]
19. New therapeutic perspectives on protein-bound uremic toxins in chronic kidney disease.
Malyszko J
Expert Opin Ther Targets; 2014 Feb; 18(2):109-13. PubMed ID: 24283253
[TBL] [Abstract][Full Text] [Related]
20. Adsorption capacity of poly(ether imide) microparticles to uremic toxins.
Tetali SD; Jankowski V; Luetzow K; Kratz K; Lendlein A; Jankowski J
Clin Hemorheol Microcirc; 2016; 61(4):657-65. PubMed ID: 26639769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
